+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Enteric Disease Testing Market by Product (Consumables, Kits, Reagents), Disease Type (Bacterial, Parasitic, Viral), Diagnostic Techniques, Testing Site - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674144
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Enteric Disease Testing Market size was estimated at USD 4.31 billion in 2023, USD 4.54 billion in 2024, and is expected to grow at a CAGR of 5.47% to reach USD 6.26 billion by 2030.

Enteric disease testing encompasses a variety of diagnostic procedures aimed at identifying pathogens that cause infectious diseases affecting the gastrointestinal tract. Given the critical role of early and accurate diagnosis in managing and preventing the spread of these diseases, the need for enteric disease testing is driven by factors such as the growing global prevalence of enteric diseases, advancements in diagnostic technologies, and increased awareness and healthcare spending. However, the practice faces challenges such as the high costs associated with advanced testing technologies, limited accessibility in low-resource settings, and the need for skilled personnel to conduct and interpret tests.

To address these issues, there is an ongoing focus on developing cost-effective and user-friendly diagnostic solutions that can be deployed widely, including in resource-constrained environments. The integration of molecular diagnostics, point-of-care testing, and the application of artificial intelligence and machine learning to improve test accuracy and speed is expected to diversify the testing procedures.

Regional Insights

In the Americas, especially the United States and Canada, there is a high adoption rate of advanced diagnostic solutions, including molecular diagnostics and point-of-care testing, driven by robust healthcare systems and high healthcare expenditure. Companies in this region benefit from a conducive regulatory environment and significant investment in R&D, leading to rapid innovation and production of enteric disease testing solutions. The APAC region has a growing demand for enteric disease diagnostics due to increasing awareness of diseases such as cholera and typhoid coupled with rising healthcare spending.

However, the market is characterized by a mix of advanced and traditional diagnostic practices, with significant variations in healthcare infrastructure across countries. Production in APAC is growing, with local companies emerging alongside established global players. EMEA presents a diverse picture, with highly developed markets in Western Europe employing cutting-edge diagnostic technologies while countries in Africa and parts of the Middle East grapple with challenges related to access and affordability of enteric disease testing. Regulatory environments across EMEA vary widely, affecting the pace of adoption of new technologies. Companies operating in EMEA are balancing innovation with cost-effective production to meet the needs of a diverse patient population.

Market Trends by Segment

  • Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
  • Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Clears MeMed BV Direct from Whole Blood

MeMed announced that its innovative MeMed BV test, designed for rapid differentiation between bacterial and viral infections, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for whole blood samples. This significant milestone allows healthcare professionals to leverage the MeMed Key analyzer, a leading-edge point-of-care device, to diagnose infections accurately in as little as 15 minutes. This breakthrough underscores MeMed's commitment to advancing host response technology and improving patient care by enabling timely and precise treatment decisions.

Avacta Acquires European Diagnostic Test Maker

Avacta Group, a notable entity in the biotechnology sector, strategically expanded its portfolio by acquiring Coris Bioconcept SRL, a distinguished European producer of rapid diagnostic test kits. Coris Bioconcept specializes in developing, manufacturing, and commercializing lateral flow tests primarily intended for use by healthcare professionals. The company boasts a robust global distribution network, reaching markets across Europe, Asia, South America, Africa, and Oceania, enhancing its presence and operational reach in diagnostic testing.

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

Merck, internationally known as MSD, announced its strategic move to acquire Prometheus Biosciences, Inc., a company in the biotechnological realm focusing on precision medicine methodologies for immune-mediated diseases. This acquisition set the transaction at an impressive total equity value of around USD 10.8 billion. Prometheus, recognized for its innovative approach to developing therapeutic and companion diagnostic solutions, is currently in the clinical stage. This partnership underscores Merck's commitment to advancing healthcare solutions by integrating cutting-edge technology and scientific research into its comprehensive portfolio.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMérieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Mérieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TÜV SÜD AG.

This research report offers invaluable insights into various crucial aspects of the Enteric Disease Testing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
5.1.2. Restraints
5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
5.1.3. Opportunities
5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
5.1.4. Challenges
5.1.4.1. Regulations concerning the approval and commercialization of product
5.2. Market Segmentation Analysis
5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Enteric Disease Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Kits
6.4. Reagents
7. Enteric Disease Testing Market, by Disease Type
7.1. Introduction
7.2. Bacterial
7.3. Parasitic
7.4. Viral
8. Enteric Disease Testing Market, by Diagnostic Techniques
8.1. Introduction
8.2. Immunoassays
8.3. Molecular Diagnostics
8.4. Rapid Diagnostics
9. Enteric Disease Testing Market, by Testing Site
9.1. Introduction
9.2. In-Hospital
9.3. Point-of-Care
9.4. Standalone Laboratories
10. Americas Enteric Disease Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Enteric Disease Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Enteric Disease Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Clears MeMed BV Direct from Whole Blood
13.3.2. Avacta Acquires European Diagnostic Test Maker
13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 103. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 106. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 107. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 108. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 109. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 110. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 111. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 112. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 113. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 114. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 115. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 116. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 117. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 120. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 121. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 122. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 123. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 124. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 125. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 126. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 127. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 128. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 129. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 130. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 177. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 180. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 181. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 182. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 183. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 184. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 185. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 186. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 187. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 188. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 189. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 190. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 191. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 194. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 195. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 196. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 197. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 198. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 199. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 200. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 201. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 202. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 203. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 204. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 205. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 208. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 209. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 210. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 219. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 222. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 223. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 224. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 225. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 226. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 227. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 228. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 229. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 230. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 231. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 232. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 233. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 236. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 237. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 238. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 247. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 250. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 251. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 252. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 261. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 264. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 265. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 266. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 275. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 278. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 279. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 280. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 289. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 292. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 293. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 294. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 303. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 306. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 307. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 308. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 309. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 310. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 311. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 312. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 313. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 314. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 315. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
TABLE 316. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
TABLE 317. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 318. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 319. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 320. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 321. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
TABLE 322. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
TABLE 323. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
TABLE 324. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Als Limited
  • Asure Quality
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerica Inc.
  • bioMérieux SA
  • Bureau Veritas Group
  • Cepheid Inc.
  • Coris BioConcept SPRL
  • DiaSorin
  • Eurofins Scientific SE
  • Hardy Diagnostics
  • Intertek Group PLC
  • Merck & Co., Inc.
  • Merck KGAA
  • Meridian Bioscience Inc.
  • Mérieux NutriSciences Corporation
  • Neogen Corporation
  • Nova Biologicals
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • Romer Labs Division Holding GmbH
  • SGS SA
  • Symbio Laboratories
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • TÜV SÜD AG

Methodology

Loading
LOADING...

Table Information